Abstract
We sequenced 46 Vibrio cholerae isolates from Cameroon, Niger, and Nigeria, 37 of which were from 2018–2019. These sequences belong to the T12 lineage observed in the region since 2009, suggesting continuous transmission. Data were generated during a workshop in Nigeria, providing a model for future regionally coordinated surveillance efforts.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for this project was provided by Bill and Melinda Gates Foundation OPP1195157.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Johns Hopkins Bloomberg School of Public Health Institutional Review Board waived ethical approval for this study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Raw data for all sequenced isolates are available at NCBI under BioProject accession: PRJNA616029.
